Our goal for Therafind is to make it easy for our members to offer potential clients a real sense of who they are and what they have to offer before they even speak for the first time.
Arlington, TX (PRWEB) April 11, 2012
Therafind is an exciting new tool for psychotherapists and other mental health professionals who are looking to grow their practice and connect with new clients. This new beta application is loaded with features that will be familiar to users of the other popular directories on the market, including searchable and optimized professional directory listings for members. Therafind hopes to build on this successful formula by offering an expanded toolset that will provide therapists with new opportunities to showcase themselves to potential clients in a deeper, more personal way.
With photos, blogs, forums, and a video introduction, all of which can be created with tools included on the website, members can build out a rich online presence. By allowing members to include a link out to existing websites, having a Therafind profile will also help therapists optimize their own websites for search engines. These features all contribute to the overall purpose: enhancing online visibility for members and helping clients locate their perfect therapist on the web.
In addition to the features already in place with the beta launch, Therafind will soon begin hosting webinars and workshops featuring experts covering a variety of topics that are most important to therapists and for creating and maintaining a successful practice.
Therafind is currently seeking a population of 100 mental health professionals to serve as Beta Testers. A brief feedback form will be administered to this group on a bi-weekly basis for the first three months to monitor satisfaction and potential areas of improvement. In exchange for this feedback, the Beta Test population will receive a free year of membership. To register as a Beta Tester, please go to http://www.therafind.com/marketplace/memberships.htm and enter the coupon code TFBETA.